Category: Penny Stocks

Pitney Bowes Inc PBI reported a first-quarter FY23 sales decline of 10% year-on-year to $834.54 million, missing the analyst consensus of $864.65 million. The global shipping and mailing company reported an adjusted $(0.01) loss, missing the consensus of $0.00. Softer-than-expected revenue per parcel, coupled with cross-border headwinds, dragged quarterly performance. Global Ecommerce revenue … Continue reading Why Pitney Bowes (PBI) Shares Are Falling Today – Pitney Bowes (NYSE:PBI)

NEW YORK, April 29, 2023 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against SVB Financial Group (“SVB” or the “Company”) SIVBQ and reminds investors of the May 12, 2023 deadline to seek the role of lead plaintiff in a federal securities class action that has been … Continue reading SVB DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In SVB To Contact Him Directly To Discuss Their Options – SVB Finl Gr (OTC:SIVBQ)

Gainers Aclarion, Inc. ACON shares surged 152% to $1.85 amid the publication of durability data for the company’s back pain treatment. IN8bio, Inc. INAB gained 111.7% to $2.2446 after the company announced new data from the Phase 1 investigator-sponsored trial of INB-100 in leukemia patients. Tempo Automation Holdings, Inc. TMPO climbed 60.5% … Continue reading Why IDEAYA Biosciences Shares Are Trading Higher By Around 27%? Here Are Other Stocks Moving In Monday’s Mid-Day Session – Aditxt (NASDAQ:ADTX), Aclarion (NASDAQ:ACON)

Relay Therapeutics RLAY shares are trading higher after Raymond James upgraded the stock from Outperform to Strong Buy and announced a $29 price target. Also, the stock is rebounding following yesterday’s sell-off. What to Know: On Wednesday, Raymond James alongside other analysts adjusted their price targets and ratings for Relay Therapeutics after clinical data was … Continue reading Why Relay Therapeutics Stock Is Trading Higher Today – Relay Therapeutics (NASDAQ:RLAY)

Regulators in New Jersey dealt a major setback to Curaleaf Holdings Inc CURLF, the state’s leading cannabis company, by denying its request for a license renewal to cultivate and sell recreational marijuana. According to New Jersey Monitor, the unexpected vote left observers surprised and Curaleaf representatives contemplating legal action and seeking intervention from the attorney general. … Continue reading New Jersey Regulators Deny Curaleaf’s License Renewal Amid Labor & Social Equity Concerns – Curaleaf Holdings (OTC:CURLF), Green Thumb Industries (OTC:GTBIF)

The Benzinga Cannabis Capital Conference, renowned as the world’s largest and most successful cannabis investing and finance event is being held at the iconic Fountainbleu Hotel in Miami Beach on April 11-12, 2023. You Won’t Want To Miss This With over 3,000 industry operators, investors, policymakers and advocates expected to attend, it is expected that 90% of the total cannabis market … Continue reading Twitter, Uber, Investors, Cannabis Companies And Advocates Converging Soon In Miami – Curaleaf Holdings (OTC:CURLF), Ayr Wellness (OTC:AYRWF)

Quantum computing uses quantum mechanics to perform operations. Quantum mechanics is a physics theory that describes the physical environment at an atomic and subatomic scale, compared to traditional physics, which looks at the macroscopic scale.  Bits denote data in classical computing. These bits are two-state, the familiar 1 or 0. With quantum computing, quantum bits … Continue reading Is 2023 The Year Of Quantum Computing Startups And A 1 Million Qubit Machine? – IonQ (NYSE:IONQ)

Franklin Covey Co. FC reported weaker-than-expected results for its second quarter on Wednesday. Franklin Covey posted quarterly earnings of $0.12 per share, missing analysts’ estimates of $0.13 per share. The company’s quarterly sales came in at $61.76 million versus expectations of $62.40 million. Franklin Covey shares dropped 17.8% to trade at $36.33 on Thursday. These … Continue reading Franklin Covey Gets Price Targets Cuts By Analysts After Downbeat Q2 Results, Shares Plunge – Franklin Covey (NYSE:FC)

SAN DIEGO, March 24, 2023 /PRNewswire/ — CV Sciences, Inc. CVSI (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the year and fourth quarter ended December 31, 2022, before the … Continue reading CV SCIENCES, INC. TO ANNOUNCE YEAR END AND FOURTH QUARTER 2022 RESULTS ON MARCH 29, 2023 – CV Sciences (OTC:CVSI)

U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 400 points on Monday. The Dow traded up 1.27% to 32,267.56 while the NASDAQ rose 0.28% to 11,663.46. The S&P 500, also rose, gaining, 0.92% to 3,952.53. Check This Out: Top 5 Tech Stocks Which You’ll Regret Missing This Quarter   … Continue reading Nasdaq Turns Higher; Credit Suisse Shares Plummet – Credit Suisse Group (NYSE:CS), Aziyo Biologics (NASDAQ:AZYO)